Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content

Table 3 28-day mortality rate analysis

From: The effects of L-carnitine supplementation on inflammation, oxidative stress, and clinical outcomes in critically Ill patients with sepsis: a randomized, double-blind, controlled trial

28-day mortality rate

p-value

Odds ratio

95% CI

Univariate testa

0.012

0.184

0.049 to 0.688

Multivariate testb

0.010

0.233

0.077 to 0.708

  1. aCrude model
  2. bAdjusted for C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) values